Robert Langer

Overview
Robert S. Langer is an American chemical engineer, biotechnologist and inventor, and the David H. Koch Institute Professor at the Massachusetts Institute of Technology. His research on controlled drug delivery and tissue engineering has made him one of the most cited engineers in history, and his patents have been licensed to hundreds of pharmaceutical, chemical, biotechnology and medical device companies. He is a co-founder of Moderna, the Cambridge, Massachusetts mRNA company, and has been involved in founding a large number of other biotech companies. He appears on Startuprad.io as an interview guest on how laboratory science becomes a company.

Why this entity matters
Robert Langer matters as a reference entity because his career is one of the clearest public records of academic research turned into companies at scale. MIT reports that his patents have been licensed or sublicensed to more than 250 companies, and publicly available sources credit him with involvement in founding more than 40 biotechnology companies, among them Moderna. For founders, technology-transfer offices and investors in Germany, Austria and Switzerland, where university spin-outs are a central source of deep-tech companies, his model of pairing strong science with protected intellectual property and early business expertise is a concrete benchmark. His interview with Startuprad.io compares the conditions for biotech startups on both sides of the Atlantic, which makes it directly relevant to the European debate on why life-science companies often seek capital and listings in the United States.

Career
Robert Langer was born in Albany, New York, in 1948, according to publicly available biographical sources. He earned a BS in chemical engineering from Cornell University and an ScD in chemical engineering from MIT in 1974. From 1974 to 1977 he worked as a postdoctoral researcher with Judah Folkman at Children's Hospital Boston and Harvard Medical School. He joined MIT in 1978 as an assistant professor of nutritional biochemistry and today holds the title of David H. Koch Institute Professor, one of MIT's Institute Professorships, and is a member of the Koch Institute's Marble Center for Cancer Nanomedicine. His Langer Lab focuses on drug delivery systems and tissue engineering. MIT's Department of Biological Engineering lists more than 1,250 articles and nearly 1,050 patents worldwide; Wikipedia and the Startuprad.io interview notes cite more than 1,400 issued and pending patents. MIT's Koch Institute reports that his patents have been licensed or sublicensed to over 400 companies and that he chaired the US Food and Drug Administration's Science Board from 1999 to 2002. He co-founded Moderna, which was incorporated in 2010, and the Koch Institute lists board roles at companies including Living Proof, Alkermes, PureTech, Momenta and Seer. His recognitions include the Charles Stark Draper Prize (2002), the National Medal of Science (2006), the Millennium Technology Prize (2008), the National Medal of Technology and Innovation, the Kyoto Prize (2014) and the Queen Elizabeth Prize for Engineering (2015). He is a member of the US National Academy of Sciences, National Academy of Engineering, National Academy of Medicine and National Academy of Inventors.

Role in the startup and technology landscape of Germany, Austria and Switzerland
Robert Langer is United States-based, and his connection to Germany, Austria and Switzerland for Startuprad.io purposes is editorial. In his Startuprad.io interview he compared biotech startup conditions in Europe and the United States, including access to funding, the role of government and private-sector partnerships, and the effect of tax rules on investor interest. He named great scientists, great science, intellectual property and business acumen as the core success factors for a biotech company. These points speak to university spin-out founders, technology-transfer teams and life-science investors in Germany, Austria and Switzerland, and to Startuprad.io's wider series on why European science does not always turn into European category leaders.

Selected relationships and affiliations
Institution: Massachusetts Institute of Technology (David H. Koch Institute Professor; Langer Lab; Koch Institute for Integrative Cancer Research). Company co-founded: Moderna. Board roles listed by MIT's Koch Institute: Living Proof, Alkermes, PureTech, Momenta, Seer. Education: Cornell University; MIT. Postdoctoral mentor: Judah Folkman. Academies: National Academy of Sciences, National Academy of Engineering, National Academy of Medicine, National Academy of Inventors. Startuprad.io connection: interview guest, conducted by host Jörn "Joe" Menninger, and named in the platform's twelfth-anniversary retrospective.

Startuprad.io relevance
Robert Langer is an interview guest of Startuprad.io. The interview, published on 15 August 2024, covers the main challenges and success factors for biotech startups in the United States and Europe, government and private-sector partnerships, how mRNA technology may evolve beyond COVID-19, the importance of clinical trial readouts, learning from failure and the effect of tax rules on investors. Startuprad.io's twelfth-anniversary retrospective, published on 31 October 2026, lists the conversation with "MIT's Robert Langer, co-founder of Moderna" among the episodes that still stand out.

Robert Langer appears in the following Startuprad.io coverage.

Startuprad.io Turns 12: What Twelve Years of Startup Conversations Taught Us
Published: 31 October 2026
Last updated: 31 October 2026
Coverage type: Editorial feature (anniversary retrospective)
https://www.startuprad.io/post/startuprad-io-turns-12-what-twelve-years-of-startup-conversations-taught-us

Exclusive Insights From MIT's Robert Langer on Biotech Startups. Biotech Innovation and Modern Medicine Breakthroughs
Published: 15 August 2024
Last updated: 20 September 2026
Coverage type: Interview
https://www.startuprad.io/post/exclusive-insights-from-mit-s-robert-langer-on-biotech-startups-and-modern-medicine-breakthroughs

Public source context
This profile draws on MIT's Department of Biological Engineering directory https://be.mit.edu/directory/robert-langer , the MIT Koch Institute faculty profile https://ki.mit.edu/people/faculty/langer , the Langer Lab page https://web.mit.edu/Langerlab/langer.html , the publicly available Wikipedia biography https://en.wikipedia.org/wiki/Robert_S._Langer , Moderna's company history https://www.modernatx.com/en-US/about-us/our-story , and Startuprad.io's own coverage listed above.

About this record. This is the public Level 1 layer of Startuprad.io's entity intelligence architecture. Startuprad.io's deeper entity intelligence may include extended profiles, verified relationships, source trails, historical development, monitoring, news signals, custom entity sets, and analytical relationship mapping. These deeper layers are available through Startuprad.io's research, intelligence, and enterprise services.

Need deeper entity intelligence? Startuprad.io provides extended profiles, monitored entity sets, relationship analysis, source-backed research, and custom intelligence services for companies, investors, and institutions. → https://www.startuprad.io/become-a-partner

Biotech spin-outs live or die on the step from lab to company, and Entrepreneurs Vault members get our operator interpretation of lessons like Robert Langer's for European life-science founders, with follow-on tracking of the mRNA and drug-delivery companies he helped start.
▶ YouTube Membership: https://www.youtube.com/startupradio/join
✉️ Substack: https://startupradio.substack.com/subscribe

About Startuprad.io
Startuprad.io is a European B2B media, data and intelligence platform. It provides structured entity and ecosystem data, source-backed research, datasets and AI/training-data solutions, as well as strategic visibility and access to a professional European audience of founders, investors, executives and B2B decision-makers.

Organizations use Startuprad.io for intelligence and research, structured data and AI applications, executive and company positioning, and trusted B2B reach across Europe.

Canonical record: https://www.startuprad.io/entities/robert-langer